Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on Dentsply Sirona (NASDAQ:XRAY) but lowered the price target from $51 to $41.

November 03, 2023 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Dentsply Sirona's price target has been lowered from $51 to $41 by Barrington Research, though the 'Outperform' rating is maintained.
The news directly pertains to Dentsply Sirona as the company's price target has been lowered by Barrington Research. However, the 'Outperform' rating is maintained, indicating that the analyst still expects the stock to outperform the market. This could have a neutral impact on the stock's price in the short term as the lower price target might be a negative signal, but the maintained 'Outperform' rating could offset this.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100